ArticleFrontiers in pharmacology2022

Efficacy and Safety of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors as Adjuvant Treatments for Patients with Hypercholesterolemia Treated with Statin: A Systematic Review and Network Meta-analysis.

Yi-Ting Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.